Your browser doesn't support javascript.
loading
Dual preparation of plasma and platelet concentrates in platelet additive solution from platelet concentrates in plasma using a novel filtration system.
Hayashi, Tomoya; Hayashi, Akihiro; Fujimura, Yoshihiro; Masaki, Mikako; Kishikawa, Tatsuya; Sakaguchi, Hirokazu; Tanaka, Mitsunobu; Kimura, Takafumi; Tani, Yoshihiko; Takihara, Yoshihiro; Hirayama, Fumiya.
Afiliação
  • Hayashi T; Japanese Red Cross Kinki Block Blood Centre, Ibaraki, Japan.
  • Hayashi A; Advanced Materials Research Laboratories, Toray Industries, Inc., Otsu, Japan.
  • Fujimura Y; Japanese Red Cross Kinki Block Blood Centre, Ibaraki, Japan.
  • Masaki M; Japanese Red Cross Kinki Block Blood Centre, Ibaraki, Japan.
  • Kishikawa T; Advanced Materials Research Laboratories, Toray Industries, Inc., Otsu, Japan.
  • Sakaguchi H; Advanced Materials Research Laboratories, Toray Industries, Inc., Otsu, Japan.
  • Tanaka M; Japanese Red Cross Kinki Block Blood Centre, Ibaraki, Japan.
  • Kimura T; Japanese Red Cross Kinki Block Blood Centre, Ibaraki, Japan.
  • Tani Y; Central Blood Institute, Japanese Red Cross, Tokyo, Japan.
  • Takihara Y; Japanese Red Cross Kinki Block Blood Centre, Ibaraki, Japan.
  • Hirayama F; Japanese Red Cross Kinki Block Blood Centre, Ibaraki, Japan.
Vox Sang ; 117(1): 49-57, 2022 Jan.
Article em En | MEDLINE | ID: mdl-34082471
ABSTRACT
BACKGROUND AND

OBJECTIVES:

Platelet concentrates suspended in a platelet additive solution (PAS-PC) are associated with a reduction in allergic response and are suitable for preparing pathogen-inactivated PC. We aimed to develop an efficient platform for the dual preparation of PAS-PC and platelet-poor plasma. MATERIALS AND

METHODS:

PAS-PC was prepared in six steps by using a hollow-fibre system based on cross-flow filtration priming, loading PC, loading PAS, collection of filtered liquid (flow-through) and collection of platelets by washing with PAS followed by washing with air. In this study, the efficacy of platelet and plasma protein recovery and characteristics of recovered PAS-PC and flow-through plasma were analysed in detail.

RESULTS:

Recoveries of platelet in PAS-PC and plasma protein in the flow-through were 95.4% ± 3.7% and 61.6% ± 5.0%, respectively. The residual plasma protein in PAS-PC was 34.1% ± 2.8%. Although the expression level of CD62P, a platelet activation marker, in recovered platelets was approximately 1.2-fold of that in original platelets, swirling patterns were well retained, and aggregation in PAS-PC was not visible. Agonist-induced aggregabilities, platelet morphology and hypotonic shock recovery were conserved. The patterns of plasma protein and lipoprotein in the flow-through were comparable with those in the original PCs. The multimeric pattern analysis of VWF remained unaltered.

CONCLUSION:

We propose a highly efficient preparation system that enables the simultaneous production of PAS-PC and platelet-poor plasma. It also achieves a high recovery of functionally well-retained platelets with very low activation.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Preservação de Sangue / Ativação Plaquetária Limite: Humans Idioma: En Revista: Vox Sang Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Preservação de Sangue / Ativação Plaquetária Limite: Humans Idioma: En Revista: Vox Sang Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão